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and How to Measure It?Y. Chandrashekhar, MD,* Jagat Narula, MD, PHDy“Throughout the whole history of science most of
the really great discoveries which had ultimately
proved to be beneﬁcial to mankind had been
made by men and women who were driven not
by the desire to be useful but merely the desire
to satisfy their curiosity.”
—Abraham Flexner (1)A previous Editor’s Page in the Journal focusedon the challenges faced by authors, re-viewers, editors, and readers during a time
when science and medical publishing are exploding
with new information (2). Nearly 35 trillion gigabytes
of published research data are expected to be avail-
able within a decade (3), and a related question is
how quality should be assessed in this vast expanse.
Traditionally, the prestige of the journal in which
research was published provided the imprimatur of
quality. Currently, despite clear limitations and
almost universal criticism, the impact factor (IF), a
measure of the number of times papers are cited in
other publications, seems to persist as the de facto
measure of quality (4). An exchange in the Guardian
(5) between Randy Schekman, the 2013 Nobel laure-
ate in medicine and physiology, and the editors of 3
of the highest-rated journals underscores the difﬁ-
culty of this issue. Philip Campbell, the Editor-in-
Chief of Nature, although concerned with the undue
inﬂuence of IFs, suggests that “it is up to the scientiﬁc
community to decide how much importance they
want to place on papers that appear in the journal”
(6). On the other hand, a survey of more thanVA Medical
edicine at20,000 scientists showed that the reputation of the
journal and its IF were among the top 3 criteria for
choosing a journal in which to publish. Dr. Schekman
takes the opposite view, suggesting that deﬁning the
prestige of a journal through its IF makes for luxury
journals that seek exclusivity by making waves to
increase subscriptions rather than publishing the
highest-quality research.
The IF of a journal depends on many factors and
does not indicate the quality of any individual piece
of research, especially because many papers, even in
high-quality journals, may be rarely cited (7). The
determinants of citation include both perceived sci-
entiﬁc value and a host of nonscientiﬁc factors. Thus,
citation count is not always linked to journal quality,
and the deﬁnition of quality still remains elusive.
CONSEQUENCES OF A “QUALITY RATING”
Perceived journal quality has implications beyond
where to publish, bragging rights after publication, or
the satisfaction that comes from enlarging the enve-
lope of science. Promotions, salaries, incentives,
and research grants depend on publishing in elite
journals, and these factors, in turn, can critically
affect an investigator’s ability to publish his or her
work in these very journals. Subject areas that are
encouraged become trendy, and there is relentless
gravitation to ﬁelds fostered by such journals, which
can distort scientiﬁc progress and misrepresent
its value to society (8). More recently, nations and
research enterprises have incorporated this into
their calculations of the rate of return for scientiﬁc
output of universities, research institutions, and in-
vestigators. Multiple experiments in this domain,
especially in the social sciences, have yielded mixed
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1703results. The sensitivity of this topic is evident in
the controversies about criteria envisaged for pro-
ductivity, and it has fomented revolt from journal
editors and researchers and, in some cases, even
political intervention (9).
WHAT IS QUALITY IN A JOURNAL?
In the early “bibliometric period,” journal quality
depended on subjective impressions and quasi-
objective criteria, like the prestige and reputation of
the learned body represented by a journal, the grav-
itas of its editorial board, low manuscript acceptance
rates, robust readership, or subscription volume.
These were acceptable in more genteel times but are
insufﬁcient for the high-stakes “publish or perish”
environment of modern academia and the ﬁercely
competitive economic landscape of the publishing
industry. Complex scientiﬁc metrics are developing
but remain inadequate (10). Despite this evolution,
top-tier journals are too often still identiﬁed by
difﬁcult-to-quantify terms to reﬂect prestige, impact,FIGURE 1 Trends in Publishing in 3 Highest-Cited Cardiology Journa
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as the cornerstone of quality, but several eminent
scientists, like the 2002 Nobel laureate Sidney
Brenner, have argued that this index hinders the
quality of science (11). Although nearly every editor is
uncomfortable with it (4), IF somehow survives and
even thrives as the imprimatur of quality.
ANOTHER LOOK AT IF AS A SURROGATE
OF JOURNAL QUALITY?
The use of IF as the currency of quality can introduce
subtle bias favoring activities that enhance IF. IF
correlates with prestige, but the relationship may be
stronger in the minds of clinicians (12) than in-
vestigators (13). Although a miniscule number of
journals focus primarily on IF, the race toward quality
may have subconsciously changed the publishing
landscape, for example, reducing the number of
elements in the “denominator”—like the number of
papers published—or increasing the number of review
articles (Figure 1). Some have suggested that thisls
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1704metric makes top journals restrictive and channels
papers into winner and loser pigeonholes to the
detriment of science.
Drs. Schekman and Brenner (5,11), among others,
lament that a paper can be often cited because it de-
scribes good science or because it is eye-catching,
provocative, or even wrong. A few frequently cited
papers can cast disproportionate prestige upon
uncited papers published in a high-impact journal. In
fact, a substantial proportion of papers in the most
highly regarded journals have low citation rates, and
some are never cited at all (7,14). Citations generally
improve with time, but approximately 20% to 35% of
papers in the top 3 cardiology journals were not cited
between 2007 and 2013 (Figure 1). The situation may
be even worse in other specialties (7), leading to the
famous quip (14) that most academic papers are read
by about 3 people—the author, the reviewer, and the
editor. Publishing a low-impact paper in a journal
with a high IF can, therefore, lead to inaccurate
assessment of a paper’s quality, inﬂating the prestige
of the researcher, and overestimating the impact of
his or her current or future work. Various types of
papers affect IF differently, and it is often unclear
whether a journal’s high IF indicates that many pa-
pers are cited many times or a few papers are cited
overwhelmingly. This is not captured by the overall
IF and has not been well investigated.
In this issue of the Journal, Nuti et al. (15) used the
Gini coefﬁcient (a parameter of interest to economists
for assessing income inequality) to determine whether
there is an association between a journal’s citation
distribution (variation) and its IF. Among 129 cardiol-
ogy journals, those with a higher IF had a lower Gini
coefﬁcient (i.e., higher-quality journals exhibited
more balanced distribution of citations, and the
quality of papers [as deﬁned by IF] was uniformly
high, rather than limited to just a few papers that were
frequently cited). This relationship was less robust
among the 4 highest-impact journals (Gini coefﬁcient
0.45 to 0.68, whereas the median value for the whole
group was 0.54), suggesting that the types of manu-
scripts published (e.g., reviews, guidelines, and posi-
tion papers) were a powerful determinant of IF. As a
corollary, high-impact papers published in some
journals contributed disproportionately to IF. The
editors routinely have tomake strategic decisions, and
some decisions may inadvertently favor some types
of manuscripts over others (indirectly inﬂuencing
the direction of science as Schekman [5] and others
have suggested). The editors of other journals may not
have access to certain types of papers, because spe-
cialty societies generally publish guidelines in their
own vehicles. During the period from 2010 to 2012,guidelines represented 6.4% of total articles in
Circulation, 2.9% in JACC, and 2.3% in the European
Heart Journal (EHJ), but accounted for a high portion
of citations: 22.4% for Circulation, 17.7% for the EHJ,
and 8.3% in JACC (H. Krumholz et al., personal
communication, March 2015). Gini coefﬁcients tight-
ened (less inequality in IF between the top 4 journals)
when these types of papers were removed: changing
by 8% for Circulation, 4% for EHJ, and 2%
for JACC. Nuti et al. (15) did not parse the effects
of “massively cited” paper types (e.g., guidelines,
consensus statements, or white papers vs. original ar-
ticles), so ﬁrm conclusions cannot be drawn. Unlike
data concerning reviews from the published pathology
data (16), guidelines or papers of similar format are the
most frequently cited papers in cardiology and rank
among the 10most-often cited papers in each of the top
3 cardiology journals: Circulation: 7 of 10; JACC: 7 of 10;
and EHJ: 9 of 10 (2011 to 2015, from a Scopus database
search performed February 21, 2015). Updated versions
of these landmark papers continue to have sustained
high impact, as exempliﬁed by the heart disease and
stroke statistics paper, which appears 5 times among
the 10 most-cited papers during this period.
WHAT IS THE FUTURE OF ASSESSING
JOURNAL QUALITY?
As discussed in a previous Editor’s Page (2), despite
the lack of agreed-upon criteria for quality, publishing
only high-quality papers is the hallmark of a high-
quality journal and the dream of every editor. Many
other ranking tools are available, such as SCImago
Journal Rank, or Google metrics. Like IF, these deal
with mean values and are not a good index of the
quality of any individual paper. It is difﬁcult to antic-
ipate how current metrics will endure when newer
journals use “soundness” rather than “soundness þ
signiﬁcance” as their criteria for publishing. Will
future paradigms (17) like letting the “marketplace or
end user review” rather than peer review comport with
current concepts of “quality?” Newer measures, such
as altmetrics, which provide dynamic, real-time ana-
lyses, are novel ways to assess publication data. These
have not yet deeply penetrated the “quality” fabric,
but several journals display these measures as re-
ﬂections of quality. The web-savvy reader might
respond better to popularity on socialmedia, reference
managers, or Twitter feeds, whereas a scientiﬁc
investigator might wonder if downloads, page views,
or dwell times on papers are appropriate indicators for
the prestige of their research.
The future of assessing journal quality is un-
charted. As publishing is commercialized, a truly free
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the way brokers trade in goods and services; in an
extreme scenario, seminal papers may even become
“Veblen goods.” On the other hand, national pro-
grams like the research excellence framework may
spawn tiers of quality that might make where a
paper is published less important than publishing in
any highly rated journal tier (9), making quality a
more amorphous concept. Given that the differences
in quality between the top journals in a ﬁeld like
cardiology are smaller than the IF differences be-
tween them suggest, this may be a reasonable
by-product of evolution. People will publish and read
what suits their interests or what ﬁts with their
area of expertise without worrying about a speciﬁc
number. Journals may wish to publish more in the
areas they want to showcase without having to worry
about what is “hot” in other areas or in competing
journals.
The current creative disruption in publishing could
generate a new pecking order for journals based on
newer indexes of quality. As new metrics abound, it
will be increasingly difﬁcult to identify 1 journal as an
undisputed leader. In both general science and clin-
ical medicine, the proportion of top (1% to 5%) cited
papers published in elite journals has already fallen,
as highly cited papers appear in other journals with
lesser reputations (18). In business and in politics, theleader is the one people choose to follow, and this will
probably continue to apply to journals. As consumers
become more inﬂuential, editors will probably shep-
herd science with the end user in mind, investigators
will become more mindful about explaining why their
work is important to society, and society will more
vigorously seek a tangible return on its investment in
science. Having said that, it is ironic that despite its
ﬂaws and forceful repudiation, the use of IF as a
surrogate of quality refuses to go away. In a recent
survey (19), a majority of researchers disdained the
use of these metrics for promotion and tenure de-
cisions. However, when asked what they consider
the best criteria for evaluating researchers, their top
answer was “publication in high-impact journals”—in
other words, high IF journals. And, although we see
the value of measurement, we cannot help but be
fearful that the coming tsunami of scientometrics
may cloud the very rationale for research. As Richard
Feynman would say, “the pleasure of ﬁnding a thing
out, the kick in the discovery, the observation that
other people use it” (20). Caveat lector and caveat
emptor.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Jagat Narula, Icahn School of Medicine at Mount
Sinai, One Gustave L. Levy Place, New York, New
York 10029. E-mail: jagat.narula@mountsinai.org.RE F E RENCE S1. Flexner A. The usefulness of useless knowledge.
Harper’s Magazine 1939;129:544–52.
2. Chandrashekhar Y, Narula J. Challenges for a
research publication: quantity, quality, and crowd
wisdom. J Am Coll Cardiol 2014;64:622–5.
3. Mark Ware Consulting. Unlocking the value
of research data. Available at: http://www.
markwareconsulting.com/science-2-0/unlocking-
the-value-of-research-data. Accessed March 11,
2014.
4. San Francisco DORA. San Francisco Declaration
on Research Assessment. Available at: http://am.
ascb.org/dora/. Accessed March 11, 2014.
5. Schekman R. How journals like Nature, Cell and
Science are damaging science. The Guardian.
December 9, 2013. Available at: http://www.
theguardian.com/commentisfree/2013/dec/09/
how-journals-nature-science-cell-damage-science.
Accessed March 11, 2015.
6. Nature. A statement from Dr. Philip Campbell,
Editor-in-Chief of Nature. Available at: http://
www.nature.com/press_releases/editor-statement.
html. Accessed March 11, 2014.
7. Lariviere V, Gingras Y, Archambault E. The
decline in the concentration of citations,1900-2007. Physics and Society 2008;arXiv:
0809.5250.
8. Bishop D. The big grant money. The big papers.
Are we missing anything? Times Higher Education
January 15, 2015.
9. Pontille D, Torny D. The controversial policies
of journal ratings: evaluating social sciences and
humanities. Research Evaluation 2010;19:347–60.
10. Lane J. Let’s make science metrics more sci-
entiﬁc. Nature 2010;464:488–9.
11. Dzheng L. How academia and publishing are
destroying scientiﬁc innovation: a conversation
with Sydney Brenner. Available at: http://
kingsreview.co.uk/magazine/blog/2014/02/24/how-
academia-and-publishing-are-destroying-scientiﬁc-
innovation-a-conversation-with-sydney-brenner/.
Accessed March 11, 2015.
12. Saha S, Saint S, Christakis DA. Impact factor: a
valid measure of journal quality? J Med Libr Assoc
2003;91:42–6.
13. Foster WR. Impact factor as the best opera-
tional measure of medical journals. Lancet 1995;
346:1301.
14. Eveleth R. Academics write papers arguing
over how many people read (and cite) theirpapers. Available at: http://www.smithsonianmag.
com/smart-news/half-academic-studies-are-
never-read-more-three-people-180950222/
#kP32tmkiQpdjvUZ0.99. Accessed March 25, 2014.
15. Nuti SV, Ranasinghe I, Murugiah K, et al.
Association between journal citation distribution
and impact factor: a novel application of the
Gini coefﬁcient. J Am Coll Cardiol 2015;65:
1711–2.
16. Ketcham CM, Crawford JM. The impact of re-
view articles. Lab Invest 2007;87:1174–85.
17. Derrick GE, Pavone V. Democratising re-
search evaluation: achieving greater public
engagement with bibliometrics-informed peer
review. Science and Public Policy 2013;40:
563–75.
18. Larivière V, Lozano GA, Gingras Y. Are elite
journals declining? J Am Soc Infor Sci Tech 2014;
65:649–55.
19. Abbott A, Cyranoski D, Jones N, Maher B,
Schiermeier Q, Van Noorden R. Metrics: do metrics
matter? Nature 2010;465:860–2.
20. Feynman RP. The Pleasure of Finding Things
Out: The Best Short Works of Richard P. Feynman.
New York, NY: Perseus Books, 1999.
